Authors:
ROUSSELOT P
LABAUME S
MAROLLEAU JP
LARGHERO J
BROUET JC
FERMAND JP
Citation: P. Rousselot et al., ARSENIC TRIOXIDE AND MELARSOPROL INDUCE APOPTOSIS IN MYELOMA CELLS IN-VITRO AND INHIBIT PLASMA-CELLS GROWTH IN-VIVO, British Journal of Haematology, 102(1), 1998, pp. 328-328
Authors:
COSTELLO R
SAINTY D
FERMAND JP
DELMER A
DIVINE M
MAROLLEAU JP
GASTAUT JA
DOMBRET H
CHAIBI P
Citation: R. Costello et al., PLASMA-CELL LEUKEMIA (PCL) - A MULTICENTRIC RETROSPECTIVE STUDY, British Journal of Haematology, 102(1), 1998, pp. 356-356
Authors:
AGBALIKA F
MARIETTE X
MAROLLEAU JP
FERMAND JP
BROUET JC
Citation: F. Agbalika et al., DETECTION OF HUMAN-HERPESVIRUS-8 DNA IN BONE-MARROW BIOPSIES FROM PATIENTS WITH MULTIPLE-MYELOMA AND WALDENSTROMS MACROGLOBULINEMIA, Blood, 91(11), 1998, pp. 4393-4394
Authors:
NAJEAN Y
RAIN JD
LEJEUNE F
ECHARD M
FERMAND JP
GRUYER P
BRAHIMI S
Citation: Y. Najean et al., TREATMENT OF POLYCYTHEMIA - II - RANDOMIZ ED PROTOCOL IN POLYCYTHEMIA-VERA PATIENTS COMPARING HYDROXYUREA AND PIPOBROMAN, Annales de medecine interne, 149(2), 1998, pp. 94-100
Authors:
PIZZUTI P
PERTUISET E
CHAUMONNOT F
CHESNEAU A
MIKOL J
LEBLONDMISSENARD V
FERMAND JP
Citation: P. Pizzuti et al., MENINGEAL AND CEREBRAL INVOLVEMENT IN MUL TIPLE-MYELOMA - 3 NEW CASESAND REVIEW OF THE LITERATURE, La Revue de medecine interne, 18(8), 1997, pp. 646-651
Authors:
MALPHETTES M
MAROLLEAU JP
BRECHIGNAC S
RABIAN C
AUTRAN B
DEBRE P
BROUET JC
FERMAND JP
Citation: M. Malphettes et al., IMMUNE RECONSTITUTION AFTER CD34(-MYELOMA() PURIFIED AUTOLOGOUS PBSC TRANSPLANTATION PATIENTS WITH MULTIPLE), Blood, 90(10), 1997, pp. 4464-4464
Authors:
ROUSSELOT P
LABAUME S
LARGHERO J
NOGUERA ME
BROUET JC
FERMAND JP
Citation: P. Rousselot et al., ARSENIC TRIOXYDE (AS2O3) AND MELARSOPROL INDUCE MYELOMA CELL APOPTOSIS IN-VITRO WITH A PREFERENTIAL EFFECT ON TUMORAL CELLS IN PATIENTS BONE-MARROW, Blood, 90(10), 1997, pp. 1451-1451
Authors:
ROUX S
FERMAND JP
BRECHIGNAC S
MARIETTE X
KAHN MF
BROUET JC
Citation: S. Roux et al., TUMORAL JOINT INVOLVEMENT IN MULTIPLE-MYELOMA AND WALDENSTROMS MACROGLOBULINEMIA - REPORT OF 4 CASES, Journal of rheumatology, 23(12), 1996, pp. 2175-2178
Authors:
SIBILIA J
DURANDY A
SCHAEVERBEKE T
FERMAND JP
Citation: J. Sibilia et al., HYPER-IGM SYNDROME-ASSOCIATED WITH RHEUMATOID-ARTHRITIS - REPORT OF RA IN A PATIENT WITH PRIMARY IMPAIRED CD40 PATHWAY, British journal of rheumatology, 35(3), 1996, pp. 282-284
Authors:
FEYDY A
SIBILIA J
DEKERVILER E
ZAGDANSKI AM
CHEVRET S
FERMAND JP
BROUET JC
FRIJA J
Citation: A. Feydy et al., CHEST HIGH-RESOLUTION CT IN ADULTS WITH PRIMARY HUMORAL IMMUNODEFICIENCY, British journal of radiology, 69(828), 1996, pp. 1108-1116
Authors:
MAROLLEAU JP
BRICE P
DALCORTIVO L
FERMAND JP
ROBERT I
MICLEA JM
CHAIBI P
GISSELBRECHT C
MILLS B
KUNKEL L
OLDHAM F
BENBUNAN M
Citation: Jp. Marolleau et al., CD34-300) FOR PATIENTS WITH MALIGNANCIES( SELECTION BY IMMUNOMAGNETICSELECTION (ISOLEX(R)), Blood, 88(10), 1996, pp. 427-427
Authors:
FERMAND JP
RAVAUD P
CHEVRET S
DIVINE M
LEBLOND V
BELANGER C
DREYFUS F
TROUSSARD X
BRECHIGNAC S
MARIETTE X
BROUET JC
Citation: Jp. Fermand et al., EARLY VERSUS LATE HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION IN MULTIPLE-MYELOMA (MM) - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL, Blood, 88(10), 1996, pp. 2730-2730
Authors:
FERMAND JP
RAVAUD P
CHEVRET S
LEBLOND V
DIVINE M
DREYFUS F
BELANGER C
TROUSSARD X
MARIETTE X
BROUET JC
Citation: Jp. Fermand et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL INVOLVING 167 PATIENTS, Stem cells, 13, 1995, pp. 156-159
Authors:
MARIETTE X
BERGOT C
RAVAUD P
ROUX C
LAVALJEANTET M
BROUET JC
FERMAND JP
Citation: X. Mariette et al., EVOLUTION OF BONE DENSITOMETRY IN PATIENTS WITH MYELOMA TREATED WITH CONVENTIONAL OR INTENSIVE THERAPY, Cancer, 76(9), 1995, pp. 1559-1563
Authors:
FERMAND JP
RAVAUD P
CHEVRET S
DIVINE M
LEBLOND V
BELANGER C
DREYFUS F
TROUSSARD X
BRECHIGNAC S
MARIETTE X
BROUET IC
Citation: Jp. Fermand et al., HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION (ABSCT) VERSUS CONVENTIONAL CHEMOTHERAPY WITH HDT RESCUE IN MULTIPLE-MYELOMA (MM) - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL, Blood, 86(10), 1995, pp. 808-808
Authors:
CALLAERT S
RAVAUD P
VIENSBITKER C
DREYFUS F
HAZEBROUCQ G
AMOR B
BROUET JC
FERMAND JP
Citation: S. Callaert et al., COST OF INTENSIVE THERAPY FOLLOWED BY AUT OLOGOUS BLOOD STEM-CELL - TRANSPLANTATION IN MULTIPLE-MYELOMA, La Presse medicale, 23(15), 1994, pp. 694-698
Citation: X. Mariette et al., MYELOMA CELL CONTAMINATION OF PERIPHERAL-BLOOD STEM-CELL GRAFTS IN PATIENTS WITH MULTIPLE-MYELOMA TREATED BY HIGH-DOSE THERAPY, Bone marrow transplantation, 14(1), 1994, pp. 47-50